Dry Needling of the M. Obliquus Capitis Inferior on Rotational Mobility and Headache Related Outcome Measures in CH.
Effect of Dry Needling of the M. Obliquus Capitis Inferior on Rotational Mobility and Headache Related Outcome Measures in Patients With Cervicogenic Headache: a Randomized, Controlled Experimental Study
1 other identifier
interventional
60
1 country
1
Brief Summary
An experimental study will be conducted to evaluate the effect of dry needling on the M. Obliquus capitis inferior on rotational mobility and headache realted outcome measures in patients with cervicogenic headache.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 29, 2021
CompletedFirst Posted
Study publicly available on registry
October 12, 2021
CompletedStudy Start
First participant enrolled
March 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedNovember 9, 2023
November 1, 2023
3.8 years
September 29, 2021
November 8, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in Atlanto-axial rotational mobility after dry needling or sham needling assessed by the flexion-rotation test.
Changes in Atlanto-axial rotational mobility after dry needling or sham needling will be assessed by the flexion-rotation test at baseline, immediately after needling (DN or SN); immediately after manual therapy and 1 week after treatment. Measurements will be registered with the digital EasyAngle Goniometer (Meloq). The change in Atlanto-axial rotational mobility after dry needling will be compared with the change Atlanto-axial rotational mobility after sham needling. Atlanto-axial rotational mobility be expressed in degrees.
Baseline, Immediately after needling (DN or SN), immediately after manual therapy, 1 week after the needling intervention.
Secondary Outcomes (10)
Changes in headache pain intensity
Baseline, immediately after the intervention (needling + manual therapy), 1 week after the needling intervention.
Changes in neck related disability
Baseline, immediately after the intervention (needling + manual therapy), 1 week after the needling intervention.
Changes in headache related disability
Baseline, immediately after the intervention (needling + manual therapy), 1 week after the needling intervention.
Changes in Global Perceived Effect
immediately after the intervention (needling + manual therapy), 1 week after the needling intervention.
Changes in headache impact.
Baseline, immediately after the intervention (needling + manual therapy), 1 week after the needling intervention.
- +5 more secondary outcomes
Study Arms (2)
Dry needling
EXPERIMENTALA single dry needling session will be performed with the subject lying in prone position. A trained physiotherapist will penetrate the needle into skin surface, fascia,into the muscle tissue at the MTrP location of the M. Obliquus Capitis Inferior, and will move the needle up and down to elicit local twitch responses.In case local twitch responses are elicited, this will be repeated until the local twitch responses are extinct. Afterwards, a rotational muscle energy technique will be applied to the atlanto-axial level.
Sham needling
SHAM COMPARATORA single sham needling session will be performed with the subject lying in prone position. A trained physiotherapist will penetrate the needle into the skin surface at the MTrP location. The fascia and muscle tissue will not be penetrated. Afterwards, a rotational muscle energy technique will be applied to the atlanto-axial level.
Interventions
Dry needling (DN) is a myofascial treatment technique, in which a thin, solid filiform needle is inserted directly into the MTrP. During dry needling, local twitch responses (LTR) can be elicited. These are involuntary contractions of muscle fibers, leadi
During sham needling, a solid, filiform needle is inserted in the skin surface at the trigger point location, without penetrating the fascia and muscle tissue.
Eligibility Criteria
You may qualify if:
- Diagnosis of cervicogenic headache according to the ICHD-3 criteria:
- A. Any headache fulfilling criterion C B. Clinical and/or imaging evidence1 of a disorder or lesion within the cervical spine or soft tissues of the neck, known to be able to cause headache2
- C. Evidence of causation demonstrated by at least two of the following:
- headache has developed in temporal relation to the onset of the cervical disorder or appearance of the lesion
- headache has significantly improved or resolved in parallel with improvement in or resolution of the cervical disorder or lesion
- cervical range of motion is reduced, and headache is made significantly worse by provocative manœuvres
- headache is abolished following diagnostic blockade of a cervical structure or its nerve supply D. Not better accounted for by another ICHD-3 diagnosis3;4;5.
- Age: 18-65 years
- Headache for at least 1 day/week for at least 3 months
- Limited mobility of the neck
- Positive flexion-rotation test (\<32 degrees on the left/right side or a difference of 10 degrees or more between left and right side)
- NRS \> 3/10
You may not qualify if:
- Primary headache forms: migraine, TTH
- Other secondary headaches that do not comply with the ICDH-3 criteria for CH
- Whiplash or other traumatic incident in the past
- Pregnancy or given birth in the last year
- Previous head, neck or shoulder surgery
- Cervical radiculopathy complaints
- Fear of needles
- Receiving other treatments for headache or neck pain (physical therapy/ostheopathy/chiropraxie...) in the previous month
- All possible contra-indications for dry needling (taking anti-coagulantia; infectional diseases; skin abnormalties in the head/neck-region; epilepsia; allergies for latex, nickel...)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Ghentlead
Study Sites (1)
University Ghent - campus UZ Ghent - Rehabilitation Sciences B3
Ghent, 9000, Belgium
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Barbara Cagnie, Prof.
University Ghent
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 29, 2021
First Posted
October 12, 2021
Study Start
March 1, 2022
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
November 9, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share